Serum Evaluation of Helicobacter pylori in Patients with Multiple Sclerosis

被引:0
|
作者
Meshkat, Mojtaba [1 ]
Behjati, Yeganeh [2 ]
Bakhshi, Mansooreh [3 ]
Meshkat, Zahra [4 ]
Mehr, Mina Yazdan [3 ]
Boostani, Reza [5 ]
Saeidi, Morteza [5 ]
Khoshakhlagh, Mahdieh [6 ]
Chechaklou, Amin Hooshyar [4 ]
Najjari, Mahya [3 ]
Abolbashari, Samaneh [4 ]
Gholoobi, Aida [7 ,8 ]
机构
[1] Islamic Azad Univ, Fac Med, Dept Community Med, Mashhad Med Sci, Mashhad, Razavi Khorasan, Iran
[2] Mashhad Univ Med Sci, Student Res Comm, Mashhad, Razavi Khorasan, Iran
[3] Mashhad Univ Med Sci, Dept Microbiol & Virol, Fac Med, Mashhad, Razavi Khorasan, Iran
[4] Mashhad Univ Med Sci, Antimicrobial Resistance Res Ctr, Mashhad, Razavi Khorasan, Iran
[5] Mashhad Univ Med Sci, Ghaem Hosp, Dept Neurol, Mashhad, Razavi Khorasan, Iran
[6] Mashhad Univ Med Sci, Dept Biochem, Fac Med, Mashhad, Razavi Khorasan, Iran
[7] Mashhad Univ Med Sci, Metab Syndrome Res Ctr, Mashhad, Razavi Khorasan, Iran
[8] Mashhad Univ Med Sci, Med Genet Res Ctr, Mashhad, Razavi Khorasan, Iran
关键词
Helicobacter pylori; Multiple Sclerosis; Serology; IgG Antibodies; INFECTION; RISK;
D O I
10.5812/ans-133607
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Multiple sclerosis (MS) is an autoimmune inflammatory disorder of the central nervous system of unknown etiology, which is believed to be caused by immune dysregulation triggered by genetic and environmental factors, leading to demyelination and axonal loss. Researchers consider infectious agents, like Helicobacter pylori, as these environmental factors. H. pylori can permanently infect someone's stomach and cause an acute or chronic inflammatory response, in which inflammatory mediators affect the brain and cause a pathologic disease. Methods: In this cross-sectional study, 38 patients with multiple sclerosis who were referred to the Neurology Clinic of Ghaem Hospital were included, and their serum samples were analyzed for IgM, IgA, and IgG antibodies against H. pylori by using enzyme-linkedimmunosorbentassay (ELISA). Resultswerecomparedwith the samples of 41 sex- andage-matched controls admitted to other wards of Ghaem Hospital & had no symptoms of MS. In the end, we analyzed the data with SPSS v.20. Results: In this study, 79 patients, including 38 patients with MS disease in the case group and 41 healthy individuals in the control group, were studied. These two groups had no significant differences in demographic characteristics, including age, gender, and occupation. H. pylori seropositivity was significantly higher in patients with MS than in controls (68.4% vs 39%) (P = 0.009). In addition, comparing H. pylori seropositivity in 20 of 30 patients with relapsing-remitting MS versus 6 of 8 patients with progressive MSsuggested a significant difference between these two groups (P = 0.030). Also, H. pylori seropositivityhadnosignificant difference between males and females (39.1% vs 58.9%). Conclusions: The prevalence of H. pylori seropositivity was significantly higher in patients with MS than in control, besides this seems more frequent in a progressive type of MS than in a relapsing-remitting one, suggesting that H. pylori might be a causal factor for developing & progressing MS and this may have an adverse impact on the prognosis and course of the disease.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Impact of Helicobacter pylori on multiple sclerosis-related clinically isolated syndrome
    Deretzi, G.
    Gavalas, E.
    Boziki, M.
    Tsiptsios, D.
    Polyzos, S. A.
    Venizelos, I.
    Zavos, C.
    Koutlas, E.
    Tsiptsios, I.
    Katsinelos, P.
    Kountouras, J.
    ACTA NEUROLOGICA SCANDINAVICA, 2016, 133 (04): : 268 - 275
  • [42] Helicobacter pylori infection as a protective factor against multiple sclerosis risk in females
    Pedrini, Marzena J. Fabis
    Seewann, Alexandra
    Bennett, Kirsten A.
    Wood, Alex J. T.
    James, Ian
    Burton, Jason
    Marshall, Barry J.
    Carroll, William M.
    Kermode, Allan G.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2015, 86 (06): : 603 - 607
  • [43] Impact of Helicobacter pylori infection on serum gastrin in haemodialysis patients
    Gür, G
    Boyacioglu, S
    Gül, C
    Turan, M
    Gürsoy, M
    Baysal, C
    Özdemir, N
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (11) : 2688 - 2691
  • [44] Influences of Helicobacter pylori on serum pepsinogen concentrations in dialysis patients
    Tamura, H
    Tokushima, H
    Murakawa, M
    Matsumura, O
    Itoyama, S
    Mitarai, T
    Isoda, K
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (01) : 113 - 117
  • [45] Serum bactericidal activity against Helicobacter pylori in patients with hypogammaglobulinaemia
    Desar, I. M. E.
    van Deuren, M.
    Sprong, T.
    Jansen, J. B. M. J.
    Namavar, F.
    Vandenbroucke-Grauls, C. M.
    van der Meer, J. W. M.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2009, 156 (03): : 434 - 439
  • [46] Association of Helicobacter Pylori Infection and Serum Albumin in Patients on Hemodialysis
    Jalalzadeh, Mojgan
    Saber, Hamid Reza
    Vafaeimanesh, Jamshid
    Mirzamohammadi, Fatemeh
    Falaknazi, Kianoosh
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2010, 4 (04) : 312 - 316
  • [47] Association of Helicobacter pylori infection and serum albumin in patients on hemodialysis
    Vafaeimanesh, Jamshid
    Bagherzadeh, Mohammad
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 235 - 236
  • [48] SERUM PEPSINOGENS AND HELICOBACTER-PYLORI INFECTION IN ELDERLY PATIENTS
    BIEMOND, I
    VEENENDAAL, RA
    LIGTHART, GJ
    LAMERS, CBHW
    GASTROENTEROLOGY, 1994, 106 (04) : A52 - A52
  • [49] EVALUATION OF LIPID LEVELS IN PATIENTS INFECTED WITH HELICOBACTER PYLORI
    Kucukazman, M.
    Yavuz, B.
    Sacikara, M.
    Asilturk, Z.
    Ata, N.
    Ertugrul, D.
    Yalcin, A.
    Kizilca, G.
    Yenigun, E.
    Ulger, Z.
    Nazligul, Y.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 83 - 83
  • [50] Diagnostic and clinical significance of antigen-specific anti-Helicobacter pylori antibodies in patients with multiple sclerosis
    Efthymiou, G.
    Dardiotis, E.
    Liaskos, C.
    Marou, E.
    Arseniou, S.
    Rikos, D.
    Tsimourtou, V.
    Meyer, W.
    Sakkas, L.
    Hadjigeorgiou, G.
    Bogdanos, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 437 - 437